Clifford Chance
David I. Schultz is a private equity partner in the New York office with extensive experience representing private equity investors and other public and private companies in complex, transformative business transactions. These include domestic and cross-border mergers, acquisitions, divestitures, joint ventures, restructurings, recapitalizations, minority investments and other complex corporate transactions.
David represents private equity sponsors in mergers and acquisitions transactions and investments in various industries, including technology, media, entertainment, retail, manufacturing, fashion/apparel, biotechnology, life settlements, telecommunications, industrials, advertising and education.
David’s extensive experience representing clients spans from advising on new investments to special situations and restructuring of existing investments in public and private companies, involving equity and debt securities at all levels of the capital structure, including negotiating governance and other control rights in connection with accumulations of significant equity and debt stakes.
- Palladium Equity Partners in connection with its investment in CircusTrix, an indoor recreation company, including multiple financing transactions, general corporate advice and strategic transactions
- Palladium Equity Partners in connection with its acquisition of Superior Environmental Solutions, an Ohio-based company providing environmental and industrial services to the chemical, refining, heavy industrial, metals and minerals, energy and transportation, food and beverage, and wastewater industries
- Palladium Equity Partners in connection with its investment in Quirch Foods, a food distribution company servicing large and independent retailers across the United States, the Caribbean, and Central and South America
- MHR Fund Management, as the largest stockholder in Lions Gate Entertainment, in connection with Lionsgate's spin-off of Starz and Lions Gate Studios into two separate US-listed public companies
- MHR Fund Management, in the sale of Emisphere Technologies, Inc. (a company developing oral formulations of GLP-1) to Novo Nordisk
- MHR Fund Management in the sale of Foresight Biotherapeutics, Inc. (a company developing topical ophthalmic drops for the treatment of infectious conjunctivitis) to Shire plc
- Apollo/Nike in connection with the sale of Tegra, a cross-border sports apparel company
- Health-E Commerce, a NY-based e-commerce company selling pre-tax health and wellness products and services, in connection with its sale to Beecken Petty O'Keefe & Company, a Chicago-based private equity fund
- Avenue Capital Group in its investments in YRC Worldwide, Ambow Education and Quiznos
- Alibaba Group in its investments in 1stdibs.com
- Alibaba, in multiple transactions as part of buildout of Alibaba's North American B2B arm
- MakerBot Industries, a New York based 3D printing company, in connection with its merger with Stratasys, Inc., a NASDAQ-listed Israeli 3D printing company
News and client work
Contact details
- Clifford Chance, New York
- +1 212 878 3197
- Email me
- Follow me on LinkedIn
- Practice area M&A corporate
- Sector Private equity
Career and qualifications
- University of Michigan (BA) 1997
- New York University School of Law (JD) 2001
- Admitted as an Attorney-at-Law in New York 2002
- Joined Clifford Chance as partner in 2024
Professional bodies
- King School Board of Trustees